Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice-Reference-Cited by-同舟云学术

Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice

Published:2005-10 Issue:4 Volume:12 Page:618-633
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Rodriguez-Lebron Edgardo,Denovan-Wright Eileen M.,Nash Kevin,Lewin Alfred S.,Mandel Ronald J.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference73 articles.

1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes;Cell,1993

2. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules;Gauthier;Cell,2004

3. Huntington’s disease: new paths to pathogenesis;Ross;Cell,2004

4. Huntingtin aggregation and toxicity in Huntington’s disease;Bates;Lancet,2003

5. Widespread expression of Huntington’s disease gene (IT15) protein product;Sharp;Neuron,1995

Cited by 240 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo CRISPR base editing for treatment of Huntington’s disease;2024-07-07

2. Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease;Archives of Pharmacal Research;2024-05-19

3. Vector-Mediated Delivery of Transgenes and RNA Interference-Based Gene Silencing Sequences to Astrocytes for Disease Management: Advances and Prospectives;Current Gene Therapy;2024-04

4. Huntingtin lowering therapeutics;Huntington's Disease;2024

5. Early whole-body mutant huntingtin lowering averts changes in proteins and lipids important for synapse function and white matter maintenance in the LacQ140 mouse model;Neurobiology of Disease;2023-10